
---
title: "BMY"
subtitle: "Stock Analysis by ChatGPT"
date: 2023-08-27T10:33:03
draft: true
tags: ['label expansion', 'positive data', 'health campaigns', 'governance initiatives', 'lawsuits impact']
author: Friday Wall
---

score:0
### Chances:
1. Bristol Myers' Opdivo receives European Commission approval for label expansion.
2. Bristol Myers Squibb showcases positive updated NSCLC data.
3. Bristol Myers Squibb launches Clear Understanding Campaign for plaque psoriasis.
4. Bristol Myers Squibb progresses in environmental, social, and governance initiatives.
5. Bristol Myers Squibb enters $4 billion accelerated share repurchase agreements.
### Risks:
1. Lawsuits against U.S. over drug pricing, potential impact on drug negotiations.
2. Mixed quarterly results reported by Pfizer and Merck due to COVID uncertainty.
3. Tumbling sales of Revlimid impacting Bristol Myers' revenue and forecast.
4. Competition and business declines affecting pharmaceutical industry stocks.
5. Insiders disposing stock at Bristol-Myers Squibb may indicate bearish signals.
### Score:0
investment score = chances characters count - risks characters count

{{<tradingview symbol="NYSE:BMY">}}
### References:
- 2023-08-25 [AstraZeneca files lawsuit against U.S. over drug pricing](https://finance.yahoo.com/video/astrazeneca-files-lawsuit-against-u-150733913.html?.tsrc=rss)
- 2023-08-25 [Retrospective Observational Study Assessing Real-World Clinical Impact of Switching or Continuing EliquisÂ® or Rivaroxaban Presented at the European Society of Cardiology (ESC) Congress 2023](https://finance.yahoo.com/news/retrospective-observational-study-assessing-real-142200001.html?.tsrc=rss)
- 2023-08-25 [AARP to join US government in two more lawsuits over Medicare drug pricing negotiations](https://finance.yahoo.com/news/aarp-to-join-us-government-in-two-more-lawsuits-over-medicare-drug-pricing-negotiations-205350458.html?.tsrc=rss)
- 2023-08-24 [Watertown biotech shares spike after accidental data publication at Roche](https://finance.yahoo.com/m/433cda4f-ecf1-3c15-8b08-eef56e8b7c0a/watertown-biotech-shares.html?.tsrc=rss)
- 2023-08-23 [Bristol Myers' (BMY) Opdivo Gets EC Nod for Label Expansion](https://finance.yahoo.com/news/bristol-myers-bmy-opdivo-gets-152800263.html?.tsrc=rss)
- 2023-08-23 [25 Most Innovative Companies Of All Time](https://finance.yahoo.com/news/25-most-innovative-companies-time-132448083.html?.tsrc=rss)
- 2023-08-23 [Bristol Myers Squibb Shares Progress Toward Its Environmental, Social, and Governance Initiatives and Its Health Equity Commitments](https://finance.yahoo.com/news/bristol-myers-squibb-shares-progress-115500414.html?.tsrc=rss)
- 2023-08-23 [Bristol Myers Squibb Receives European Commission Approval for Opdivo (nivolumab) as an Adjuvant Treatment for Patients with Completely Resected Stage IIB or IIC Melanoma](https://finance.yahoo.com/news/bristol-myers-squibb-receives-european-201800378.html?.tsrc=rss)
- 2023-08-22 [Should You Be Impressed By Bristol-Myers Squibb Company's (NYSE:BMY) ROE?](https://finance.yahoo.com/news/impressed-bristol-myers-squibb-companys-130028029.html?.tsrc=rss)
- 2023-08-22 [Medicare drug price negotiations unlikely to be derailed by lawsuits: UBS](https://finance.yahoo.com/news/medicare-drug-price-negotiations-unlikely-to-be-derailed-by-lawsuits-ubs-165832314.html?.tsrc=rss)


                